Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies
This study is ongoing, but not recruiting participants.
Study NCT00057395 Information provided by Aronex Pharmaceuticals
First Received: April 1, 2003 Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Esophageal Neoplasms
Hepatocellular Carcinoma
Colorectal Neoplasms
Ovarian Neoplasms
Pancreatic Neoplasms
Neoplasms
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Hepatocellular
Esophageal Diseases
More general conditions related to this trial
Adenocarcinoma
Adnexal Diseases
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Head and Neck Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Liver Diseases
Liver Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Ovarian Diseases
Pancreatic Diseases
Rectal Diseases
Urogenital Neoplasms
Interventions listed in this trial
Aroplatin (Liposomal NDDP, L-NDDP)
Sponsors listed in this trial
Aronex Pharmaceuticals
Back to top of Main Content
